Dr. Andreas Scherer is President and CEO of Golden Helix. The company has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over two decades. Its innovative technologies and analytic services empower clinicians and scientists at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from next-generation sequencing and microarrays. With its solutions, hundreds of the world’s hospitals, testing labs, academic research organizations, and governments are able to harness the full potential of genomics to identify the cause of disease, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in thousands of peer-reviewed publications.
He is also President and CEO of Salto Partners Inc. – a management consulting firm headquartered in Nevada. He has extensive experience successfully managing growth as well as orchestrating complex turnaround situations. Salto Partners provides board level advisory services on corporate governance, growth strategies and complex business matters such as Mergers & Acquisitions and turn-arounds.
Dr. Scherer holds a PhD in computer science from the University of Hagen, Germany, and a Master of Computer Science from the University of Dortmund, Germany. He is author and co-author of over 20 international publications and has written books on project management, the Internet, and artificial intelligence. His latest book, “Be Fast Or Be Gone”, is a prizewinner in the 2012 Eric Hoffer Book Awards competition, and has been named a finalist in the 2012 Next Generation Indie Book Awards!
“Be Fast or Be Gone is a fascinating treatment of the power of focus, applied to the often complex world of project and strategy management.”
David Allen, Best-selling author Getting Things Done: the Art of Stress-Free Productivity
“Be Fast or Be Gone will open your eyes to the possibilities of realistic schedules and on-time project completion.”
Dr. Steven D. Eppinger, Sloan School of Management, Massachusetts Institute of Technology
“Using the principles espoused in Andreas Scherer’s book Be Fast or Be Gone, pharmaceutical companies can substantially shorten their research and development timelines, allowing drugs to be available to patients much more quickly.”
Dr. Hugh Davis, Vice President, Centocor – a Johnson and Johnson company